Search company, investor...
Nebula Genomics company logo

Nebula Genomics

Founded Year



Acquired | Acquired

Total Raised




About Nebula Genomics

Nebula Genomics provides a platform for users to find genetic history and genome data. It provides customized reports on new variants, risk scores, and research for deoxyribonucleic acid (DNA) and related DNA data using its proprietary technologies. The company was founded in 2016 and is based in Garden City, New York. In August 2021, Nebula Genomics was acquired by ProPhase Labs.

Headquarters Location

711 Stewart Avenue Suite 200

Garden City, New York, 11530,

United States

Missing: Nebula Genomics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Nebula Genomics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Nebula Genomics

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Nebula Genomics in 1 CB Insights research brief, most recently on Mar 9, 2022.

Expert Collections containing Nebula Genomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nebula Genomics is included in 9 Expert Collections, including Blockchain.



5,932 items

Companies in this collection build, apply, and analyze blockchain and cryptocurrency technologies for business or consumer use cases. Various industries include financial services, trade finance, supply chain, enterprise tech, consumer and retail, and healthcare.


Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Game Changers 2018

36 items

Our selected startups are high-momentum companies pioneering technology with the potential to transform society and economies for the better.


Medical Devices

8,633 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Latest Nebula Genomics News

Global Clinical Medical Laboratory Services Market Analysis Report 2023: Molecular Diagnostics is Driving Runaway Growth - Strategy and Trends Forecasts to 2027

Apr 18, 2023

The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report. The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges. Questions? Email us at service at We would be glad to let you know if we can be of help. Key Topics Covered: 4.3.1 Traditional Automation and Centralization 4.3.2 The New Automation, Decentralization and Point Of Care 4.3.3 Instruments Key to Market Share 4.3.4 Bioinformatics Plays a Role 4.3.5 PCR Takes Command 4.3.7 NGS Impact on Pricing 4.3.8 Whole Genome Sequencing, A Brave New World 4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment 4.3.10 Shifting Role of Diagnostics 5 Clinical Laboratory Services Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section 5.2 Brooks Automation acquires Aim Lab 5.3 Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO 5.4 Mayo Clinic Laboratories and Helix to provide Biopharma Services 5.5 CompuGroup Medical acquires Medicus Laboratory Information Systems 5.6 Quest Diagnostics acquires Summa Health outreach lab 5.7 Q Solutions Launches Self-Collection Safety Lab Panel 5.8 Bionano Genomics Announces Launch of Bionano Laboratories 5.9 Labcorp to Spin Off Clinical Development Business 5.10 Value-Based Care Growing More Profitable for Labs 5.11 Lucid Diagnostics Reports Revenue Growth 5.12 NGS Cancer Testing Decision Appeases Industry 5.13 Clinical Labs Make Strong Showing in 2021 5.14 Seegene to Enter Syndromic MDx Space 5.15 EKF Diagnostics Acquires Advanced Diagnostic Laboratory 5.16 Molecular Health, EDGC Ink Liquid Biopsy Partnership 5.17 ProPhase Labs Acquires Nebula Genomics for $14.6M 5.18 Karius Cell-Free DNA Method to Detect Infection Validated 5.19 South Korean Firm EDGC to Expand Into Liquid Biopsy Space With Cf DNA Platform 5.20 TruDiagnostic Receives CLIA Certification for Kentucky Laboratory 5.21 Enzo Biochem Q2 Revenues Up 62 Percent 5.22 Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay 5.23 FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations 5.24 Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19? 5.25 Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing 5.26 Cooperative Aims to Expand Clinical, Commercial NGS Access 5.27 CDC Ranks Two More Microbes as 'Urgent Threat' 5.28 ACLA Requests $5 billion to keep private labs going 5.29 Applied Biology to Launch New Laboratory for Hair and Skin Disorders 5.30 Quest Diagnostics Acquires Outreach Operations 6 Profiles of Key Companies 6.1 Acibadem Labmed Laboratory

Nebula Genomics Frequently Asked Questions (FAQ)

  • When was Nebula Genomics founded?

    Nebula Genomics was founded in 2016.

  • Where is Nebula Genomics's headquarters?

    Nebula Genomics's headquarters is located at 711 Stewart Avenue, Garden City.

  • What is Nebula Genomics's latest funding round?

    Nebula Genomics's latest funding round is Acquired.

  • How much did Nebula Genomics raise?

    Nebula Genomics raised a total of $5.15M.

  • Who are the investors of Nebula Genomics?

    Investors of Nebula Genomics include ProPhase Labs, Paycheck Protection Program, F-Prime Capital, Windham Venture Partners, Fenbushi Capital and 10 more.

  • Who are Nebula Genomics's competitors?

    Competitors of Nebula Genomics include Akkure and 3 more.

Compare Nebula Genomics to Competitors

Helix Logo

Helix connects people with the most fundamental aspect of what makes them unique: their own DNA. The company empowers consumers to discover and explore their own genomes through insights provided by its ecosystem of content partners.


Luna offers a health and genomic data platform owned by its community of personal health information donors. It empowers individuals to share their health data for medical research and the greater good of the community. The company was founded in 2017 and is based in San Diego, California.


ADNTRO operates as a biotechnology research company. The company offers human genetics research, personalized nutrition plans, and personal health consulting and services. It specializes in GWAS, genetics, and education. It was founded in 2020 and is based in Illes Balears, Spain.

tellmeGen Logo

tellmeGen is a biotechnology research company. It helps people identify possible future illnesses and sensitivities inherent in their genes. It specializes in biotechnology, genetics, big data, computational biology, precision medicine, pharmacogenetics, and ancestry. It was founded in 2014 and is based in Valencia, Spain.

Antidote Logo

Antidote operates as a digital health company. The company uses precision recruitment to match the right patients with the right trials. It strikes the right balance between technology and human touch to deliver patient engagement through the integration of data-driven technologies, digital expertise, deep domain experience, a diverse partner network, and personalized patient and site services. The company was founded in 2010 and is based in North Miami Beach, Florida.

LetsGetChecked Logo

LetsGetChecked offers at-home tests for a variety of conditions. The company builds and delivers at-home testing kits, including hormone tests, fertility tests, HPV tests and wellness tests for cholesterol or diabetes. Its services includes manufacturing, logistics, lab analysis, clinician support, and prescription fulfillment. The company was founded in 2015 and is based in Dublin, Ireland.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.